Journal
RHEUMATOLOGY INTERNATIONAL
Volume 30, Issue 11, Pages 1503-1505Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00296-009-1098-x
Keywords
Lupus myocarditis; Treatment; Immunoglobulin
Categories
Ask authors/readers for more resources
Intravenous immunoglobulin (IVIg) is emerging as the mainstay in the treatment of many autoimmune diseases, including systemic lupus erythematosus. IVIg has been found to be beneficial in myocarditis due to dermatomyositis/polymyositis, Kawasaki disease, and viral myocarditis in children. We report an 18-year-old man of active lupus with worsening cardiac systolic function who did not respond to pulse methylprednisolone and cyclophosphamide, but subsequently showed an improvement in his cardiac function after IVIg administration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available